GS
Geeta Sadanand Rao
About Geeta Sadanand Rao
Data last updated:
Geeta Sadanand Rao has 18 years in corporate governance. Holds Whole-Time Director role. Currently with 1 company, including Supreem Pharmaceuticals Mysore Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Supreem Pharmaceuticals Mysore Private Limited at ₹82.17 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Supreem Pharmaceuticals Mysore Private Limited U24231KA1996PTC020988 | Whole-Time Director | 22 Jan 2008 | 1996 | ₹82.17 Cr (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Geeta Sadanand Rao
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Geeta Sadanand Rao
Geeta Sadanand Rao has 18 years in corporate governance. Holds Whole-Time Director role. Currently with 1 company, including Supreem Pharmaceuticals Mysore Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Supreem Pharmaceuticals Mysore Private Limited at ₹82.17 Cr (FY 2025).
Geeta Sadanand Rao is associated with 1 company as Whole-Time Director, including Supreem Pharmaceuticals Mysore Private Limited (₹82.17 Cr).
Geeta Sadanand Rao has expertise in General Business.
Geeta Sadanand Rao has 18 years in corporate governance.
By reported revenue, the largest current company of Geeta Sadanand Rao is Supreem Pharmaceuticals Mysore Private Limited, with revenue of ₹82.17 Cr (FY 2025).
Geeta Sadanand Rao currently holds positions at 1 company: Supreem Pharmaceuticals Mysore Private Limited (₹82.17 Cr).